Candyce E. Monroe

Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease

Shaila P. Handattu, David W. Garber, Candyce E. Monroe et al. · Neurobiology of Disease · 2009 · 123 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

In Vivo and In Vitro Effects of an Apolipoprotein E Mimetic Peptide on Amyloid-β Pathology

Shaila P. Handattu, Candyce E. Monroe, Gaurav Nayyar et al. · Journal of Alzheimer s Disease · 2013 · 48 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice

Shaila P. Handattu, Gaurav Nayyar, David W. Garber et al. · Atherosclerosis · 2012 · 41 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice

Gaurav Nayyar, David W. Garber, Mayakonda N. Palgunachari et al. · Atherosclerosis · 2012 · 39 citations

Medicine, Endocrinology, Genetics +4

Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice

Shaila P. Handattu, Geeta Datta, Richard M. Epand et al. · Journal of Lipid Research · 2010 · 27 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17